Breast cancer treatment often involves a combination of therapies, including surgery, radiation, and medications. Understanding the medications used can help patients and caregivers make informed decisions and manage expectations. This article explains the most common medications used in breast cancer treatment.

Hormonal Therapies

Hormonal therapies are used for hormone receptor-positive breast cancers, which rely on hormones like estrogen or progesterone to grow. These medications block hormone production or prevent hormones from binding to cancer cells.

Tamoxifen

Tamoxifen is a selective estrogen receptor modulator (SERM) that blocks estrogen receptors on breast cancer cells. It is commonly prescribed for both premenopausal and postmenopausal women and can be used for treatment and prevention.

Aromatase Inhibitors

Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, reduce estrogen production in postmenopausal women. They are effective in lowering the risk of recurrence in hormone receptor-positive breast cancers.

Chemotherapy Drugs

Chemotherapy involves drugs that kill rapidly dividing cancer cells. These medications are often used in early-stage and advanced breast cancer cases to reduce tumor size and prevent metastasis.

  • Doxorubicin: An anthracycline that damages DNA in cancer cells.
  • Cyclophosphamide: An alkylating agent that interferes with DNA replication.
  • Paclitaxel: A taxane that stabilizes microtubules, preventing cell division.

Targeted Therapies

Targeted therapies focus on specific molecules involved in cancer growth. They tend to have fewer side effects than traditional chemotherapy.

Trastuzumab (Herceptin)

Trastuzumab is a monoclonal antibody that targets the HER2 protein, which is overexpressed in some breast cancers. It can be used alone or with chemotherapy to improve outcomes.

Other Targeted Agents

Other drugs such as pertuzumab and ado-trastuzumab emtansine (T-DM1) are also used to target HER2-positive breast cancers, often in combination with trastuzumab.

Immunotherapy

Immunotherapy is an emerging area in breast cancer treatment, especially for triple-negative breast cancer. Drugs like atezolizumab are designed to help the immune system recognize and attack cancer cells.

Overall, the choice of medication depends on the type and stage of breast cancer, as well as patient health and preferences. Consulting with an oncologist is essential to determine the most effective treatment plan.